Obesity trials recruiting in New Hampshire

All Obesity trials nationally

Cities in New Hampshire

Recruiting trials in New Hampshire

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New Hampshire: Portsmouth
• Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early Life
  NCT06534541 · Phase: Not applicable (e.g. observational or device study) · Ages: 27 Months to 72 Months · Sex: All (male and female) · New Hampshire: Hanover
• International Weight Control Registry
  NCT04907396 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New Hampshire: Durham
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New Hampshire: Lebanon
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New Hampshire: Lebanon
• Phentermine's Impact on Treatment in Teens
  NCT07282340 · Phase: Phase 2 · Ages: 12 Years to 17 Years · Sex: All (male and female) · New Hampshire: Lebanon
• The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
  NCT05912348 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 30 Years · Sex: All (male and female) · New Hampshire: Durham